Krystal Biotech, Inc. (KRYS)
300.88
+0.63
(+0.21%)
USD |
NASDAQ |
Nov 06, 16:00
299.88
-1.00
(-0.33%)
After-Hours: 20:00
Krystal Biotech Net Income (TTM) : 225.17M for Sept. 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 225.17M |
| June 30, 2026 | 241.46M |
| March 31, 2026 | 225.03M |
| December 31, 2025 | 204.83M |
| September 30, 2025 | 198.91M |
| June 30, 2025 | 146.72M |
| March 31, 2025 | 123.96M |
| December 31, 2024 | 89.16M |
| September 30, 2024 | 52.37M |
| June 30, 2024 | 105.94M |
| March 31, 2024 | 57.16M |
| December 31, 2023 | 10.93M |
| September 30, 2023 | -29.81M |
| June 30, 2023 | -140.41M |
| March 31, 2023 | -135.31M |
| December 31, 2022 | -139.98M |
| September 30, 2022 | -129.73M |
| June 30, 2022 | -115.47M |
| March 31, 2022 | -103.72M |
| December 31, 2021 | -69.57M |
| Date | Value |
|---|---|
| September 30, 2021 | -58.15M |
| June 30, 2021 | -52.17M |
| March 31, 2021 | -42.64M |
| December 31, 2020 | -32.17M |
| September 30, 2020 | -27.14M |
| June 30, 2020 | -21.80M |
| March 31, 2020 | -20.32M |
| December 31, 2019 | -19.09M |
| September 30, 2019 | -17.44M |
| June 30, 2019 | -15.92M |
| March 31, 2019 | -12.85M |
| December 31, 2018 | -10.89M |
| September 30, 2018 | -8.574M |
| June 30, 2018 | -11.09M |
| March 31, 2018 | -9.575M |
| December 31, 2017 | -7.919M |
| September 30, 2017 | -7.153M |
| June 30, 2017 | -2.202M |
| March 31, 2017 | -1.644M |
| December 31, 2016 | -1.15M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 2.724B |
| Ionis Pharmaceuticals, Inc. | -564.78M |
| Ultragenyx Pharmaceutical, Inc. | -524.00M |
| BridgeBio Pharma, Inc. | -577.58M |
| Cytokinetics, Inc. | -777.89M |